Literature DB >> 31786551

Contemporary and emerging magnetic resonance imaging methods for evaluation of moyamoya disease.

Vance T Lehman1, Petrice M Cogswell1, Lorenzo Rinaldo2, Waleed Brinjikji1, John Huston1, James P Klaas3, Giuseppe Lanzino2.   

Abstract

Numerous recent technological advances offer the potential to substantially enhance the MRI evaluation of moyamoya disease (MMD). These include high-resolution volumetric imaging, high-resolution vessel wall characterization, improved cerebral angiographic and perfusion techniques, high-field imaging, fast scanning methods, and artificial intelligence. This review discusses the current state-of-the-art MRI applications in these realms, emphasizing key imaging findings, clinical utility, and areas that will benefit from further investigation. Although these techniques may apply to imaging of a wide array of neurovascular or other neurological conditions, consideration of their application to MMD is useful given the comprehensive multidimensional MRI assessment used to evaluate MMD. These MRI techniques span from basic cross-sectional to advanced functional sequences, both qualitative and quantitative.The aim of this review was to provide a comprehensive summary and analysis of current key relevant literature of advanced MRI techniques for the evaluation of MMD with image-rich case examples. These imaging methods can aid clinical characterization, help direct treatment, assist in the evaluation of treatment response, and potentially improve the understanding of the pathophysiology of MMD.

Entities:  

Keywords:  3D-TOF = 3D time-of-flight; ASL = arterial spin labeling; BOLD = blood oxygen level–dependent; CBF = cerebral blood flow; CBV = cerebral blood volume; CVR = cerebrovascular reactivity; DKI = diffusion kurtosis imaging; DSC = dynamic susceptibility contrast; DTI = diffusion tensor imaging; DWI = diffusion-weighted imaging; ECA = external carotid artery; ICA = internal carotid artery; MCA = middle cerebral artery; MIP = maximum intensity projection; MMD = moyamoya disease; MMS = moyamoya syndrome; MTT = mean transit time; OEF = oxygen extraction fraction; PD = proton density; STA = superficial temporal artery; SWI = susceptibility-weighted imaging; TTP = time to peak; VWI = vessel wall imaging; cerebral perfusion; cerebrovascular reactivity; fMRI = functional MRI; magnetic resonance angiography; moyamoya disease; rsfMRI = resting-state fMRI; vessel wall imaging

Mesh:

Substances:

Year:  2019        PMID: 31786551     DOI: 10.3171/2019.9.FOCUS19616

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  8 in total

1.  Recurrent transient ischemic attacks in a moyamoya syndrome patient with ultra-long imaging follow-up.

Authors:  Lan Zhang; Wei Xing; Jiajia Zhang
Journal:  Quant Imaging Med Surg       Date:  2022-03

2.  Moyamoya Disease With Initial Ischemic or Hemorrhagic Attack Shows Different Brain Structural and Functional Features: A Pilot Study.

Authors:  Junwen Hu; Yin Li; Yun Tong; Zhaoqing Li; Jingyin Chen; Yang Cao; Yifan Zhang; Duo Xu; Leilei Zheng; Ruiliang Bai; Lin Wang
Journal:  Front Neurol       Date:  2022-05-13       Impact factor: 4.086

Review 3.  Pathophysiology of Vascular Stenosis and Remodeling in Moyamoya Disease.

Authors:  Brandon M Fox; Kirsten B Dorschel; Michael T Lawton; John E Wanebo
Journal:  Front Neurol       Date:  2021-09-03       Impact factor: 4.003

Review 4.  Vessel Wall Magnetic Resonance Imaging in Cerebrovascular Diseases.

Authors:  Federico Mazzacane; Valentina Mazzoleni; Elisa Scola; Sara Mancini; Ivano Lombardo; Giorgio Busto; Elisa Rognone; Anna Pichiecchio; Alessandro Padovani; Andrea Morotti; Enrico Fainardi
Journal:  Diagnostics (Basel)       Date:  2022-01-20

Review 5.  Application of DTI and fMRI in moyamoya disease.

Authors:  Xiaokuan Hao; Ziqi Liu; Shihao He; Yanru Wang; Yuanli Zhao; Rong Wang
Journal:  Front Neurol       Date:  2022-08-05       Impact factor: 4.086

Review 6.  Implementation and Rationale for a Unified Clinical and Imaging Protocol for Evaluation and Treatment of Moyamoya Angiopathy: A Single Institutional Experience.

Authors:  Anthony S Larson; Vance T Lehman; Luis E Savastano; Giuseppe Lanzino; Norbert G Campeau; Kirk M Welker; James P Klaas
Journal:  Front Neurol       Date:  2021-05-17       Impact factor: 4.003

7.  Hemodynamic evaluation of patients with Moyamoya Angiopathy: comparison of resting-state fMRI to breath-hold fMRI and [15O]water PET.

Authors:  Leonie Zerweck; Constantin Roder; Till-Karsten Hauser; Johannes Thurow; Annerose Mengel; Marcos Tatagiba; Nadia Khan; Philipp T Meyer; Ulrike Ernemann; Uwe Klose
Journal:  Neuroradiology       Date:  2021-09-27       Impact factor: 2.804

Review 8.  Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment.

Authors:  Xin Zhang; Weiping Xiao; Qing Zhang; Ding Xia; Peng Gao; Jiabin Su; Heng Yang; Xinjie Gao; Wei Ni; Yu Lei; Yuxiang Gu
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.